Assura (LON:AGR) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened

Assura Plc (LON:AGRGet Free Report)’s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 48.45 and traded as high as GBX 48.50. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares changing hands.

Analysts Set New Price Targets

Several equities research analysts have recently commented on AGR shares. Shore Capital restated a “hold” rating on shares of Assura in a report on Wednesday, October 1st. Peel Hunt restated a “buy” rating and set a GBX 60 price objective on shares of Assura in a report on Tuesday, September 30th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of GBX 60.

Get Our Latest Research Report on Assura

Assura Stock Performance

The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. The firm’s fifty day moving average is GBX 47.47 and its two-hundred day moving average is GBX 48.45. The firm has a market capitalization of £1.54 billion, a PE ratio of 895.85, a PEG ratio of 3.60 and a beta of 0.37.

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Featured Stories

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.